Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
about
Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB).Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.Parenteral antibiotic therapy in general practice in Italy: a direct observational study.Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
P2860
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
@ast
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
@en
type
label
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
@ast
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
@en
prefLabel
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
@ast
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
@en
P1433
P1476
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.
@en
P2093
Esposito S
P304
19-28; discussion 47-9
P356
10.2165/00003495-200059003-00003
P478
59 Suppl 3
P577
2000-01-01T00:00:00Z
P6179
1021985826